— Know what they know.
Not Investment Advice

HSDT

Solana Company
1W: -2.8% 1M: +4.6% 3M: -28.6% YTD: -33.7% 1Y: -99.3% 3Y: -100.0% 5Y: -100.0%
$2.04
-0.07 (-3.32%)
After Hours: $2.19 (+0.15, +7.35%)
NASDAQ · Healthcare · Medical - Devices · $82.2M · Alpha Radar Neutral · Power 57
Smart Money Score
No convergence signal
Key Statistics
Market Cap$82.2M
52W Range1.74-366.75
Volume340,002
Avg Volume430,335
Beta0.96
Dividend
Analyst Ratings
2 Buy 2 Hold 0 Sell
Consensus Buy
Company Info
CEODane Carl Andreeff
Employees21
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-06-27
Websitesolana.com
642 Newtown Yardley Road
Newtown, PA 18940
US
215 944 6100
About Solana Company

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Recent Insider Trades

NameTypeSharesPriceDate
Jiang Cosmo Yi 0 2025-10-30
Chee Choon Wee 0 2025-09-18
Chee Choon Wee 6,830,402 $10.13 2025-09-18
Chee Choon Wee 1,109,118 2025-09-18
Favit-Van Pelt Anton A-Award 17,500 $9.76 2025-07-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms